Literature DB >> 22519951

One-year evolution of ulnar somatosensory potentials after trauma in 365 tetraplegic patients: early prediction of potential upper limb function.

Fabian Kuhn1, Pascal Halder, Martina Rebekka Spiess, Martin Schubert.   

Abstract

Early prediction of hand function is crucial for efficient rehabilitation of cervical spinal cord injury (cSCI). This study investigated correlations between ulnar somatosensory evoked potentials (ulnar SSEPs) and functional outcome of hand function following acute traumatic cervical cord injury. Neurological assessment of sensory scores and hand function were compared with five ulnar SSEP categories of similar persistence and quality in 365 patients throughout the first year after cSCI. Of the 365 patients, 218 (68%) exhibited ulnar SSEP potentials at any one stage during the year, and in 147 patients (40.3%) ulnar SSEPs were obtainable at every assessment stage. While ulnar SSEP latency and amplitude assessments remained largely unchanged over time in the majority of patients, hand function improved remarkably during the first year following cSCI. One year outcome of hand function was predetermined by ulnar SSEP category due to distinct differences in the ulnar SSEP parameters. Additionally, an early prognostic group allocation by ulnar SSEP criteria at the first assessment stage within 4 weeks after spinal trauma allowed reliable prediction of hand function outcome after 1 year. We conclude that early assessment of ulnar SSEP as a non-invasive and objective neurophysiological test is a valuable marker of prospective hand function and independence 1 year after cSCI. This could be most relevant for planning neurorehabilitation, and in prospective clinical SCI trials.

Entities:  

Mesh:

Year:  2012        PMID: 22519951     DOI: 10.1089/neu.2011.2277

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  7 in total

Review 1.  Application of electrophysiological measures in spinal cord injury clinical trials: a narrative review.

Authors:  Michèle Hubli; John L K Kramer; Catherine R Jutzeler; Jan Rosner; Julio C Furlan; Keith E Tansey; Martin Schubert
Journal:  Spinal Cord       Date:  2019-07-23       Impact factor: 2.772

Review 2.  Spinal cord injury: how can we improve the classification and quantification of its severity and prognosis?

Authors:  Vibhor Krishna; Hampton Andrews; Abhay Varma; Jacobo Mintzer; Mark S Kindy; James Guest
Journal:  J Neurotrauma       Date:  2014-02-01       Impact factor: 5.269

3.  Tracking sensory system atrophy and outcome prediction in spinal cord injury.

Authors:  Patrick Grabher; Martina F Callaghan; John Ashburner; Nikolaus Weiskopf; Alan J Thompson; Armin Curt; Patrick Freund
Journal:  Ann Neurol       Date:  2015-09-18       Impact factor: 10.422

4.  Is microdiffusion imaging able to improve the detection of cervical myelopathy? Study protocol of a prospective observational trial (MIDICAM-Trial).

Authors:  Marc Hohenhaus; Karl Egger; Jan-Helge Klingler; Ulrich Hubbe; Marco Reisert; Katharina Wolf
Journal:  BMJ Open       Date:  2019-09-03       Impact factor: 2.692

5.  Assessment of spinal cord motion as a new diagnostic MRI-parameter in cervical spinal canal stenosis: study protocol on a prospective longitudinal trial.

Authors:  Katharina Wolf; Axel J Krafft; Karl Egger; Jan-Helge Klingler; Ulrich Hubbe; Marco Reisert; Marc Hohenhaus
Journal:  J Orthop Surg Res       Date:  2019-10-12       Impact factor: 2.359

6.  Electroencephalography as a Biomarker for Functional Recovery in Spinal Cord Injury Patients.

Authors:  Marcel Simis; Deniz Doruk Camsari; Marta Imamura; Thais Raquel Martins Filippo; Daniel Rubio De Souza; Linamara Rizzo Battistella; Felipe Fregni
Journal:  Front Hum Neurosci       Date:  2021-04-09       Impact factor: 3.169

Review 7.  Improving Diagnostic Workup Following Traumatic Spinal Cord Injury: Advances in Biomarkers.

Authors:  Simon Schading; Tim M Emmenegger; Patrick Freund
Journal:  Curr Neurol Neurosci Rep       Date:  2021-07-16       Impact factor: 5.081

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.